Table 2.
Post-transplantation
|
||||||||
---|---|---|---|---|---|---|---|---|
Baseline M0 | M1 1 month | M2 2 months | M3 3 months | M4 4 months | M5 5 months | M6 6 months | P ANOVA | |
LVs | 2.03 ± 0.38 | 1.80 ± 0.34 | 1.80 ± 0.15 | 1.88 ± 0.25 | 1.88 ± 0.28 | 1.76 ± 0.25 | 1.76 ± 0.27 | 0.9009 |
LVd | 2.99 ± 0.15 | 2.67 ± 0.24 | 2.99 ± 0.12 | 3.02 ± 0.22 | 2.68 ± 0.25 | 3.02 ± 0.18 | 2.95 ± 0.20 | 0.1561 |
IVSs | 1.01 ± 0.10 | 1.04 ± 0.15 | 1.05 ± 0.08 | 1.04 ± 0.05 | 0.93 ± 0.09 | 0.95 ± 0.06 | 0.94 ± 0.06 | 0.4501 |
IVSd | 0.69 ± 0.07 | 0.83 ± 0.05 | 0.75 ± 0.08 | 0.79 ± 0.14 | 0.83 ± 0.17 | 0.66 ± 0.04 | 0.77 ± 0.17 | 0.4781 |
FWs | 1.07 ± 0.12 | 1.29 ± 0.32 | 1.16 ± 0.30 | 1.03 ± 0.10 | 1.15 ± 0.16 | 1.07 ± 0.26 | 1.12 ± 0.16 | 0.8261 |
FWd | 0.85 ± 0.15 | 0.88 ± 0.19 | 0.73 ± 0.10 | 0.69 ± 0.13 | 0.69 ± 0.18 | 0.64 ± 0.15 | 0.64 ± 0.09 | 0.3089 |
%EF | 61.00 ± 3.08 | 64.00 ± 5.72 | 65.33 ± 5.03 | 69.33 ± 6.03 | 69.33 ± 8.39 | 70.67 ± 2.08 | 68.00 ± 7.21 | 0.4066 |
%FS | 32.33 ± 9.29 | 34.33 ± 2.74 | 35.33 ± 4.04 | 38.00 ± 4.58 | 39.00 ± 2.77 | 39.00 ± 1.00 | 36.67 ± 5.13 | 0.5833 |
WSIs | 2.10 ± 0.70 | 1.70 ± 0.30 | 1.90 ± 0.20 | 1.80 ± 0.10 | 1.70 ± 0.10 | 1.60 ± 0.30 | 1.10 ± 0.30 | 0.0761 |
WSId | 4.40 ± 0.20 | 3.90 ± 0.90 | 3.90 ± 1.50 | 2.70 ± 0.40 | 2.70 ± 0.70 | 2.90 ± 0.90 | 2.90 ± 1.10 | 0.1723 |
LVs — left-ventricular end-systolic dimension (cm); LVd — left-ventricular end-diastolic dimension (cm); IVSs — interventricular septal thickeness in systole (cm); IVSd — interventricular septal thickness in diastole (cm); FWs — left-ventricular free wall thickeness in systole (cm); FWd — left-ventricular free wall thickeness in diastole (cm); %EF — ejection fraction (%); %FS — fractional shortening (%); WSIs — end-systolic wall stress index; WSId — end-diastolic wall stress index.